Your browser is no longer supported. Please, upgrade your browser.
MRNA [NASD]
Moderna, Inc.
IndexS&P 500 P/E9.83 EPS (ttm)16.28 Insider Own1.80% Shs Outstand404.00M Perf Week-23.84%
Market Cap67.92B Forward P/E5.75 EPS next Y27.86 Insider Trans-15.17% Shs Float367.00M Perf Month-40.30%
Income7.06B PEG0.59 EPS next Q9.11 Inst Own61.20% Short Float4.55% Perf Quarter-52.86%
Sales11.83B P/S5.74 EPS this Y-26.10% Inst Trans0.26% Short Ratio1.42 Perf Half Y-54.11%
Book/sh25.06 P/B6.39 EPS next Y5.96% ROA49.50% Target Price278.01 Perf Year22.17%
Cash/sh20.99 P/C7.63 EPS next 5Y16.80% ROE121.60% 52W Range117.34 - 497.49 Perf YTD-36.98%
Dividend- P/FCF5.96 EPS past 5Y- ROI-28.40% 52W High-67.82% Beta-
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin85.90% 52W Low36.41% ATR17.33
Employees1300 Current Ratio1.30 Sales Q/Q3065.00% Oper. Margin64.30% RSI (14)24.71 Volatility7.91% 7.25%
OptionableYes Debt/Eq0.05 EPS Q/Q- Profit Margin59.70% Rel Volume0.98 Prev Close167.52
ShortableYes LT Debt/Eq0.02 EarningsNov 04 BMO Payout0.00% Avg Volume11.74M Price160.07
Recom2.60 SMA20-28.50% SMA50-37.19% SMA200-42.61% Volume11,540,178 Change-4.45%
Jan-21-22Upgrade BofA Securities Underperform → Neutral $135 → $180
Jan-21-22Initiated UBS Neutral $221
Dec-07-21Initiated Cowen Market Perform
Nov-09-21Initiated Wolfe Research Outperform $304
Oct-22-21Initiated Deutsche Bank Sell $250
Oct-15-21Upgrade Piper Sandler Neutral → Overweight $445
Aug-06-21Downgrade Piper Sandler Overweight → Neutral $246 → $445
Aug-06-21Downgrade Oppenheimer Outperform → Perform
Jul-15-21Reiterated Jefferies Hold $170 → $250
Feb-01-21Downgrade BofA Securities Neutral → Underperform
Dec-16-20Downgrade Morgan Stanley Overweight → Equal-Weight $150
Dec-16-20Downgrade Jefferies Buy → Hold $90 → $150
Dec-09-20Downgrade Needham Buy → Hold
Nov-23-20Initiated Wells Fargo Equal Weight $92
Nov-17-20Downgrade BMO Capital Markets Outperform → Market Perform $109
Sep-08-20Downgrade SVB Leerink Mkt Perform → Underperform $58 → $41
Jul-23-20Initiated SVB Leerink Mkt Perform
Jul-20-20Downgrade JP Morgan Overweight → Neutral $89
Jul-13-20Initiated Jefferies Buy $90
Jun-30-20Initiated Argus Buy $80
Jan-22-22 06:00AM  
Jan-21-22 05:38PM  
05:38PM  
05:38PM  
05:07PM  
03:47PM  
03:33PM  
03:15PM  
01:59PM  
01:47PM  
12:54PM  
11:12AM  
Jan-20-22 05:38PM  
04:59PM  
04:58PM  
04:35PM  
03:43PM  
03:07PM  
01:38PM  
11:55AM  
11:43AM  
10:44AM  
09:38AM  
09:21AM  
09:08AM  
Jan-19-22 09:38PM  
09:38PM  
05:38PM  
05:38PM  
05:38PM  
04:03PM  
01:51PM  
01:38PM  
01:22PM  
10:37AM  
10:17AM  
09:38AM  
09:38AM  
09:38AM  
07:52AM  
06:30AM  
03:50AM  
Jan-18-22 03:46PM  
03:19PM  
02:53PM  
01:38PM  
01:38PM  
10:41AM  
09:38AM  
09:38AM  
08:37AM  
07:06AM  
06:18AM  
02:03AM  
Jan-17-22 11:38AM  
09:04AM  
08:59AM  
06:00AM  
06:00AM  
04:00AM  
Jan-16-22 06:54AM  
Jan-14-22 03:46PM  
02:56PM  
02:12PM  
01:39PM  
01:38PM  
01:38PM  
11:19AM  
10:18AM  
09:38AM  
08:00AM  
06:00AM  
Jan-13-22 09:38PM  
05:38PM  
01:38PM  
10:29AM  
09:38AM  
08:33AM  
08:20AM  
08:01AM  
05:52AM  
05:48AM  
Jan-12-22 05:45PM  
05:38PM  
05:28PM  
05:22PM  
05:17PM  
04:57PM  
03:42PM  
02:52PM  
01:38PM  
01:02PM  
11:40AM  
11:10AM  
11:01AM  
06:15AM  
Jan-11-22 09:38PM  
04:33PM  
03:46PM  
03:33PM  
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, Metagenomi, Inc., and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bancel StephaneChief Executive OfficerJan 20Sale175.0110,0001,750,1007,054,880Jan 21 04:06 PM
Bancel StephaneChief Executive OfficerJan 19Sale188.559,0001,696,9505,753,535Jan 21 04:06 PM
Hoge StephenPresidentJan 13Option Exercise4.2915,00064,4001,624,597Jan 14 04:16 PM
Hoge StephenPresidentJan 13Sale219.5615,0003,293,4001,609,597Jan 14 04:16 PM
Bancel StephaneChief Executive OfficerJan 13Sale219.5610,0002,195,6007,064,880Jan 14 04:20 PM
Hoge StephenPresidentJan 12Option Exercise10.905,00054,5001,614,597Jan 14 04:16 PM
Hoge StephenPresidentJan 12Sale220.015,0001,100,0501,609,597Jan 14 04:16 PM
Bancel StephaneChief Executive OfficerJan 12Sale220.019,0001,980,0905,766,535Jan 14 04:20 PM
Bancel StephaneChief Executive OfficerJan 06Sale215.3310,0002,153,3007,074,880Jan 07 04:10 PM
Bancel StephaneChief Executive OfficerJan 05Sale232.109,0002,088,9005,779,535Jan 07 04:10 PM
Hoge StephenPresidentJan 03Option Exercise0.9920,00019,8001,629,597Jan 04 04:07 PM
Hoge StephenPresidentJan 03Sale247.0820,0004,941,6001,609,597Jan 04 04:07 PM
Andres JuanSee remarksDec 31Option Exercise12.215,00061,0505,000Jan 04 04:10 PM
Andres JuanSee remarksDec 31Sale249.885,0001,249,4000Jan 04 04:10 PM
Bancel StephaneChief Executive OfficerDec 30Sale243.4210,0002,434,2007,084,880Jan 03 04:16 PM
Andres JuanSee remarksDec 29Option Exercise12.215,00061,0505,000Dec 30 05:03 PM
Bancel StephaneChief Executive OfficerDec 29Sale240.009,0002,160,0005,792,535Dec 30 05:01 PM
Andres JuanSee remarksDec 29Sale240.005,0001,200,0000Dec 30 05:03 PM
Hoge StephenPresidentDec 27Option Exercise10.905,00054,5001,614,597Dec 29 04:47 PM
Andres JuanSee remarksDec 27Option Exercise12.2110,000122,10010,000Dec 29 04:52 PM
Hoge StephenPresidentDec 27Sale243.105,0001,215,5001,609,597Dec 29 04:47 PM
Andres JuanSee remarksDec 27Sale243.1010,0002,431,0000Dec 29 04:52 PM
Hoge StephenPresidentDec 23Option Exercise4.2915,00064,4001,624,597Dec 27 04:31 PM
Bancel StephaneChief Executive OfficerDec 23Sale250.4110,0002,504,1007,094,880Dec 27 04:27 PM
Hoge StephenPresidentDec 23Sale247.3015,0003,709,5481,609,597Dec 27 04:31 PM
Andres JuanSee remarksDec 22Option Exercise12.215,00061,0505,000Dec 23 04:11 PM
Bancel StephaneChief Executive OfficerDec 22Sale264.269,0002,378,3405,805,535Dec 23 04:06 PM
Andres JuanSee remarksDec 22Sale264.265,0001,321,3000Dec 23 04:11 PM
Andres JuanSee remarksDec 20Option Exercise13.5515,000203,25015,000Dec 21 04:06 PM
Andres JuanSee remarksDec 20Sale320.9715,0004,814,5500Dec 21 04:06 PM
Andres JuanSee remarksDec 17Option Exercise12.215,00061,0505,000Dec 21 04:06 PM
Andres JuanSee remarksDec 17Sale275.685,0001,378,4000Dec 21 04:06 PM
Bancel StephaneChief Executive OfficerDec 16Sale284.2010,0002,842,0007,104,880Dec 17 04:12 PM
Andres JuanSee remarksDec 15Option Exercise12.215,00061,0505,000Dec 17 04:25 PM
Bancel StephaneChief Executive OfficerDec 15Sale272.119,0002,448,9905,818,535Dec 17 04:12 PM
Andres JuanSee remarksDec 15Sale272.115,0001,360,5500Dec 17 04:25 PM
Andres JuanSee remarksDec 13Option Exercise12.215,00061,0505,000Dec 14 04:09 PM
Hoge StephenPresidentDec 13Option Exercise5.9520,000118,9001,629,597Dec 14 04:14 PM
Andres JuanSee remarksDec 13Sale257.015,0001,285,0500Dec 14 04:09 PM
Hoge StephenPresidentDec 13Sale257.0120,0005,140,2001,609,597Dec 14 04:14 PM
Andres JuanSee remarksDec 10Option Exercise12.215,00061,0505,000Dec 14 04:09 PM
Andres JuanSee remarksDec 10Sale235.005,0001,175,0000Dec 14 04:09 PM
Bancel StephaneChief Executive OfficerDec 09Sale285.1910,0002,851,9007,114,880Dec 10 04:10 PM
Andres JuanSee remarksDec 08Option Exercise12.215,00061,0505,000Dec 10 04:08 PM
Andres JuanSee remarksDec 08Sale282.355,0001,411,7500Dec 10 04:08 PM
Bancel StephaneChief Executive OfficerDec 08Sale282.359,0002,541,1505,831,535Dec 10 04:10 PM
Andres JuanSee remarksDec 06Option Exercise13.5515,000203,25015,000Dec 07 04:07 PM
Andres JuanSee remarksDec 06Sale280.6015,0004,209,0000Dec 07 04:07 PM
Hoge StephenPresidentDec 03Option Exercise0.9910,0009,9001,619,597Dec 06 04:26 PM
Andres JuanSee remarksDec 03Option Exercise12.215,00061,0505,000Dec 07 04:07 PM
Hoge StephenPresidentDec 03Sale318.4010,0003,184,0001,609,597Dec 06 04:26 PM
Andres JuanSee remarksDec 03Sale318.405,0001,592,0000Dec 07 04:07 PM
Hoge StephenPresidentDec 02Option Exercise0.9910,0009,9001,619,597Dec 06 04:26 PM
Hoge StephenPresidentDec 02Sale301.2910,0003,012,9001,609,597Dec 06 04:26 PM
Bancel StephaneChief Executive OfficerDec 02Sale301.2910,0003,012,9007,124,880Dec 03 04:59 PM
Andres JuanSee remarksDec 01Option Exercise12.215,00061,0505,000Dec 03 05:04 PM
Bancel StephaneChief Executive OfficerDec 01Sale329.919,0002,969,1905,944,535Dec 03 04:59 PM
Andres JuanSee remarksDec 01Sale329.915,0001,649,5500Dec 03 05:04 PM
Andres JuanSee remarksNov 29Option Exercise12.215,00061,0505,000Nov 30 04:09 PM
Andres JuanSee remarksNov 29Sale370.385,0001,851,9000Nov 30 04:09 PM
Andres JuanSee remarksNov 26Option Exercise12.215,00061,0505,000Nov 30 04:09 PM
Andres JuanSee remarksNov 26Sale319.625,0001,598,1000Nov 30 04:09 PM
Bancel StephaneChief Executive OfficerNov 26Sale319.6210,0003,196,2007,134,880Nov 30 04:12 PM
Andres JuanSee remarksNov 24Option Exercise12.215,00061,0505,000Nov 26 02:08 PM
Bancel StephaneChief Executive OfficerNov 24Sale273.019,0002,457,0905,940,868Nov 26 01:59 PM
Andres JuanSee remarksNov 24Sale273.015,0001,365,0500Nov 26 02:08 PM
Hoge StephenPresidentNov 23Option Exercise4.2915,00064,4001,624,597Nov 26 02:20 PM
Hoge StephenPresidentNov 23Sale275.5215,0004,132,7721,609,597Nov 26 02:20 PM
Andres JuanSee remarksNov 22Option Exercise13.5515,000203,25015,000Nov 23 06:16 PM
Andres JuanSee remarksNov 22Sale268.1815,0004,022,7000Nov 23 06:16 PM
Andres JuanSee remarksNov 19Option Exercise12.215,00061,0505,000Nov 23 06:16 PM
Andres JuanSee remarksNov 19Sale265.715,0001,328,5500Nov 23 06:16 PM
Bancel StephaneChief Executive OfficerNov 18Sale245.8910,0002,458,9007,144,880Nov 19 04:09 PM
Andres JuanSee remarksNov 17Option Exercise12.215,00061,0505,000Nov 19 04:15 PM
Bancel StephaneChief Executive OfficerNov 17Sale234.579,0002,111,1305,953,868Nov 19 04:09 PM
Andres JuanSee remarksNov 17Sale234.575,0001,172,8500Nov 19 04:15 PM
Andres JuanSee remarksNov 15Option Exercise12.215,00061,0505,000Nov 16 04:23 PM
Hoge StephenPresidentNov 15Option Exercise4.2915,00064,4001,624,597Nov 16 04:25 PM
Andres JuanSee remarksNov 15Sale231.015,0001,155,0500Nov 16 04:23 PM
Hoge StephenPresidentNov 15Sale231.0115,0003,465,1501,609,597Nov 16 04:25 PM
Andres JuanSee remarksNov 12Option Exercise12.215,00061,0505,000Nov 16 04:23 PM
Hoge StephenPresidentNov 12Option Exercise10.905,00054,5001,614,597Nov 16 04:25 PM
Andres JuanSee remarksNov 12Sale225.865,0001,129,3000Nov 16 04:23 PM
Hoge StephenPresidentNov 12Sale225.865,0001,129,3001,609,597Nov 16 04:25 PM
Bancel StephaneChief Executive OfficerNov 11Sale227.6710,0002,276,7007,154,880Nov 12 04:07 PM
Andres JuanSee remarksNov 10Option Exercise12.215,00061,0505,000Nov 12 04:16 PM
Bancel StephaneChief Executive OfficerNov 10Sale230.009,0002,070,0005,996,868Nov 12 04:07 PM
Andres JuanSee remarksNov 10Sale230.005,0001,150,0000Nov 12 04:16 PM
Andres JuanSee remarksNov 08Option Exercise13.5515,000203,25015,000Nov 09 04:36 PM
Andres JuanSee remarksNov 08Sale233.1315,0003,496,9500Nov 09 04:36 PM
Andres JuanSee remarksNov 05Option Exercise12.215,00061,0505,000Nov 09 04:36 PM
Andres JuanSee remarksNov 05Sale240.005,0001,200,0000Nov 09 04:36 PM
Bancel StephaneChief Executive OfficerNov 04Sale295.5010,0002,955,0007,164,880Nov 05 05:04 PM
Hoge StephenPresidentNov 03Option Exercise0.9910,0009,9001,619,597Nov 04 04:43 PM
Andres JuanSee remarksNov 03Option Exercise12.215,00061,0505,000Nov 05 05:09 PM
Hoge StephenPresidentNov 03Sale350.0010,0003,500,0001,609,597Nov 04 04:43 PM
Bancel StephaneChief Executive OfficerNov 03Sale350.009,0003,150,0006,009,868Nov 05 05:04 PM
Andres JuanSee remarksNov 03Sale350.005,0001,750,0000Nov 05 05:09 PM
Hoge StephenPresidentNov 02Option Exercise0.9910,0009,9001,619,597Nov 04 04:43 PM
Hoge StephenPresidentNov 02Sale338.5410,0003,385,4001,609,597Nov 04 04:43 PM